LexaGene Holdings Inc. Aktie Toronto S.E.
Aktien
A2ATW9
CA52886L1031
LXG.H
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01.03.18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24.03.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18.06.18 |
Jack Regan
CEO | Chief Executive Officer | - | 26.04.07 |
Tom Slezak
BRD | Director/Board Member | - | 12.10.16 |
% 1. Jan. | Kap. | |
---|---|---|
-29.78% | 9.59 Mrd. | |
-2.96% | 3.21 Mrd. | |
+28.23% | 2.92 Mrd. | |
-14.73% | 2.15 Mrd. | |
-15.05% | 1.79 Mrd. | |
+69.62% | 1.47 Mrd. | |
+23.08% | 770 Mio. | |
-2.84% | 761 Mio. | |
-24.08% | 548 Mio. |